Notice of AGM
21 Novembro 2024 - 9:00PM
UK Regulatory
Notice of AGM
DXS INTERNATIONAL PLC
(AQSE: DXSP)
Notice of 2024 Annual General
Meeting
The Board of DXS International plc (“the
Company” or “DXSP”), the AQSE Growth Market quoted healthcare
information and digital clinical decision support systems provider,
is pleased to announce that its Annual General Meeting is scheduled
to take place on Thursday 19th December at Noon at Elm
House, Tanshire Park, Shackleford Road. Elstead, Surrey GU8
6LB.
For further information in relation to the AGM,
shareholders should refer to the Notice of Annual General Meeting
and the AGM Letter which have been despatched to shareholders.
Copies of these documents, along with the Company's Annual Report
for the year ended 30 April 2024, are available for download from
the Company's website
https://www.dxs-systems.co.uk/corporate-documents.php
The Directors of DXS International plc accept
responsibility for this announcement. This announcement contains
information which, prior to its disclosure, was inside information
as stipulated under Regulation 11 of the Market Abuse (Amendment)
(EU Exit) Regulations 2019/310 (as amended).
Contacts:
David
Immelman
DXS International plc
www.dxs-systems.com
|
01252 719800 |
AQSE Corporate
Broker and Corporate Advisor
Hybridan LLP
Claire Louise Noyce |
020 3764 2341 |
Notes to Editors
About DXS:
DXS International presents up to date treatment
guidelines and recommendations, from Clinical Commissioning Groups
and other trusted NHS sources, to doctors, nurses and pharmacists
in their workflow and during the patient consultation. This
effective clinical decision support ultimately translates to
improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its
projected efficiency savings.
DXS (AQSE:DXSP)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
DXS (AQSE:DXSP)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024